within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01C_BetaLactamAntibacterialsPenicillins.J01CR02_AmoxicillinAndBetaLactamaseInhibitor;

model AmoxicillinAndBetaLactamaseInhibitor
  extends Pharmacolibrary.Drugs.ATC.J.J01CR02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J01CR02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>A combination antibacterial medication consisting of amoxicillin, a broad-spectrum penicillin antibiotic, and a beta-lactamase inhibitor (commonly clavulanic acid), which extends the spectrum of amoxicillin by inhibiting bacterial beta-lactamase enzymes. It is approved and widely used today for the treatment of infections such as respiratory tract infections, urinary tract infections, skin infections, and others caused by susceptible bacteria.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after a single oral administration of amoxicillin in combination with clavulanic acid.</p><h4>References</h4><ol><li><p>Huttner, A, et al., &amp; Mouton, JW (2020). Oral amoxicillin and amoxicillin-clavulanic acid: properties, indications and usage. <i>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</i> 26(7) 871–879. DOI:<a href=&quot;https://doi.org/10.1016/j.cmi.2019.11.028&quot;>10.1016/j.cmi.2019.11.028</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31811919/&quot;>https://pubmed.ncbi.nlm.nih.gov/31811919</a></p></li><li><p>Lee, SW, et al., &amp; Chung, JY (2020). Multiple-dose pharmacokinetics and safety of amoxicillin/clavulanate in healthy elderly subjects. <i>International journal of clinical pharmacology and therapeutics</i> 58(11) 634–641. DOI:<a href=&quot;https://doi.org/10.5414/CP203773&quot;>10.5414/CP203773</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32729824/&quot;>https://pubmed.ncbi.nlm.nih.gov/32729824</a></p></li><li><p>Yang, F, et al., &amp; Wang, H (2019). Pharmacokinetics of the amoxicillin-clavulanic acid combination after intravenous and oral administration in cats. <i>Journal of veterinary pharmacology and therapeutics</i> 42(5) 511–517. DOI:<a href=&quot;https://doi.org/10.1111/jvp.12765&quot;>10.1111/jvp.12765</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31162674/&quot;>https://pubmed.ncbi.nlm.nih.gov/31162674</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end AmoxicillinAndBetaLactamaseInhibitor;
